HALE DAVID F 4
4 · Dermata Therapeutics, Inc. · Filed Oct 7, 2022
Insider Transaction Report
Form 4
HALE DAVID F
Director
Transactions
- Award
Common Stock
2022-10-06+30,155→ 75,720 total
Holdings
- 12,195(indirect: By Hale Trading Company L.P.)
Common Stock
- 35,714(indirect: By Trust)
Common Stock
- 532,925(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]On October 6, 2022, the Reporting Person was granted 30,155 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.
- [F2]Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.